GRALVSLABT• 7 Days (Normalized)
GRAL vs LABT (GRAIL Inc. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Sep 23 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GRAL Performance $136.57
+25.85%
GRAIL Inc.
Normalized Baseline0.00%
LABT Performance $0.99
-44.38%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin GRAL LEADS
+70.23 pts
GRAL outperforming by 70.23 percentage points
GRALLABT
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GRAL LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | GRAL Price | GRAL Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $136.57 | +25.85% | $0.99 | -44.38% | +70.23% |
| Sep 28, 2026 | $132.63 | +22.22% | $1.15 | -35.39% | +57.61% |
| Sep 25, 2026 | $126.89 | +16.93% | $1.67 | -6.18% | +23.11% |
| Sep 24, 2026 | $125.21 | +15.38% | $1.83 | +2.81% | +12.57% |
| Sep 23, 2026 | $108.52 | +0.00% | $1.78 | +0.00% | +0.00% |